Campbell Rogers is leaving his post as chief scientific officer for Johnson & Johnson’s (NYSE:JNJ) Cordis Corp. – a role created for him in July 2006 – to take the chief medical officer job at startup HeartFlow.
Varian Medical Systems
Cordis sues U.S. Patent Office in latest Stent War scrimmage | Legal News
Varian slides after-hours on lower Q1 profits | Earnings Roundup
Shares of Varian Medical Systems (NYSE:VAR) sank in after-hours trading yesterday as Wall Street reacted to shrinking profits during the company’s 1st quarter for fiscal 2012.
The Palo Alto, Calif.-based oncology and X-ray products maker posted $625 million in sales during the three months ended Dec. 30, 2011, up 7.8% from $580 million sold in the same period in 2010.
Goldman pans Wall Street’s med-tech estimates
Wall Street’s overall take on sales and earnings forecasts for medical device makers this year is too high, according to Goldman Sachs (NYSE:GS) analyst David Roman, who sees The Street’s 4th-quarter top-line estimates as split evenly among companies with upside and downside.
Diabetes: Roche lands FDA nod for Accu-Chek Nano | Regulatory Roundup
Roche (PINK:RHHBY) won clearance from the U.S. Food & Drug Administration for its Accu-Chek Nano SmartView blood glucose monitoring system.
The Switzerland-based biotech builder’s no code meter is smaller than a credit card that allows patients to customize test reminders, pre and post meal markers and calculate their average glucose levels.
Bankers’ outlook grim for U.S. IPOs | Wall Street Beat
Bankers aren’t expecting much excitement in the U.S. market for initial public offerings this year, as China spends another year at the top.
About half of the 100 capital markets execs surveyed predict growth in IPOs this year, compared to 72% of those surveyed in advance of 2011, according to BDO USA, an accounting and consulting firm.
Only 16% of those surveyed expected any growth to be "significant," while 35% expect flat growth and 15% predicted that the market will continue to slide.
Judge: Varian’s RPM infringes Pitt patent
A federal jury in Pennsylvania is slated to decide whether Varian Medical Systems’ (NYSE:VAR) infringement of a University of Pittsburgh patent was willful later this month, after a judge there ruled that the RPM respiratory gating system violates one of the school’s patents.
Tough times for Siemens mean up to 2,000 jobs cut
Siemens AG (NYSE:SI) may cut as many as 2,000 positions from its diagnostics and radiation treatment divisions, shifting its focus to lower-cost countries and reducing costs.
The European giant’s diagnostics arm, responsible for nearly one-third of sales in FY 2011, has lagged in the last two years, despite the $13 billion spent giving it an overhaul.
MassDevice.com +3 | Orthopedic players slide after CMS announcement, Symmetry Medical bags J&J surgical instruments arm for $165M, Breast cancer: Varian’s FDA clearance
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Breast cancer: Varian lands FDA clearance for radiotherapy device updates | Regulatory Roundup
Varian Medical Systems Inc. (NYSE:VAR) won FDA clearance to update the control software for its Clinac and Trilogy targeted radiotherapy devices and its new Pivitol Care Solution for prone breast treatment.
The software approval from the federal watchdog agency allows the Palo Alto, Calif.-based company’s devices to deliver higher doses two times faster than previously possible at 2400 monitor units per minute.
Abiomed hits 52-week high | Wall Street Beat
Abiomed (NSDQ:ABMD) shares hit $20.25 apiece yesterday, their highest mark in 52 weeks, as the company touted more positive study results for its flagship Impella heart pump.
ABMD shares closed yesterday at $20.14, up 6.2 percent on a day of widespread gains on Wall Street. The Dow Jones Industrial Average gained 4.2 percent yesterday, the S&P 500 closed up 4.3 percent and the Dow Jones medical device index rose 4.8 percent.